SERPIND1 and ovarian serous cystadenocarcinoma: And the positive and strongly positive expression rates of SERPIND1 were higher in ovarian serous cystadenocarcinoma than in ovarian mucinous cystadenocarcinoma (97.4 and 72.7% vs. 77.8 and 44.4%, P < 0.05).